Skip to content

A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502622-40-00
Acronym
IK930-001
Enrollment
31
Registered
2024-05-14
Start date
Unknown
Completion date
2024-05-28
Last updated
2024-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors

Interventions

None listed

Sponsors

Ikena Oncology Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Italy, Netherlands, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026